上海市精神卫生中心，即上海交通大学医学院附属精神卫生中心，俗称宛平南路600号、600号，是中国上海市唯一一座精神病学专科三级甲等医院，由上海市卫生健康委员会管理，是上海交通大学医学院的附属医院之一，主导上海全市精神卫生领域的医疗、教研、预防康复、心理咨询和学术交流等工作。

During the past decade, Shanghai Mental Health Center conducted 127 clinical trials. In the 10-year time frame, 127 clinical trials started and 2 clinical trials were completed, i.e. on average, 1.6% percent of trials that started reached the finish line to date. In the past 5 years, 89 clinical trials started and 2 clinical trials were completed. i.e. 2.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shanghai Mental Health Center" #1 sponsor was "Shanghai Mental Health Center" with 109 trials, followed by "Sumitomo Pharma (Suzhou) Co., Ltd." with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Peking University" with 3 trials sponsored and "Shanghai Jiao Tong University School of Medicine" with 3 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shanghai Mental Health Center" #1 collaborator was "Guangzhou Psychiatric Hospital" with 4 trials as a collaborator, "National Natural Science Foundation of China" with 4 trials as a collaborator, "Shanghai Jiao Tong University School of Medicine" with 4 trials as a collaborator, "First Affiliated Hospital of Kunming Medical University" with 3 trials as a collaborator and "Qingdao Mental Health Center" with 3 trials as a collaborator. Other collaborators include 115 different institutions and companies that were collaborators in the rest 98 trials.

According to Clinical.Site data, the most researched conditions in "Shanghai Mental Health Center" are "Schizophrenia" (37 trials), "Major Depressive Disorder" (21 trials), "Obsessive-Compulsive Disorder" (11 trials), "Alzheimer Disease" (7 trials) and "Bipolar Disorder" (6 trials). Many other conditions were trialed in "Shanghai Mental Health Center" in a lesser frequency.

Most popular intervention types in "Shanghai Mental Health Center" are "Drug" (72 trials), "Device" (40 trials), "Other" (22 trials), "Behavioral" (14 trials) and "Diagnostic Test" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "ThymatronSystem Ⅳ Electroconvulsive System" (5 trials), "Magpro X100 + Option" (4 trials), "Fluoxetine" (3 trials) and "Fluvoxamine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Shanghai Mental Health Center" are 145 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 58 active trials in "Shanghai Mental Health Center". 9 are not yet recruiting, 43 are recruiting, 3 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 42 completed trials in Shanghai Mental Health Center, 2 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Shanghai Mental Health Center, 11 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 17 trials, and there were also 59 trials that are defined as “Not Applicable".